Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antimalarial cyclic peroxy ketals

G H Posner1, H O'Dowd, P Ploypradith

  • 1Department of Chemistry, The Johns Hopkins University, Baltimore, Maryland 21218, USA.

Journal of Medicinal Chemistry
|June 17, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Physics Beyond the Standard Model in Events with High-Momentum Higgs Bosons and Missing Transverse Momentum in Proton-Proton Collisions at 13 TeV.

Physical review letters·2018
Same author

Observation of tt[over ¯]H Production.

Physical review letters·2018
Same author

Search for Heavy Neutral Leptons in Events with Three Charged Leptons in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2018
Same author

Patient features and survival of pediatric aplastic anemia in the USA: a large institution experience.

Journal of public health (Oxford, England)·2018
Same author

Search for the X(5568) State Decaying into B_{s}^{0}π^{±} in Proton-Proton Collisions at sqrt[s]=8  TeV.

Physical review letters·2018
Same author

Measurement of Prompt D^{0} Meson Azimuthal Anisotropy in Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2018
Same journal

Development of Indole-3-yl-methylene-thiobarbital Derivatives as Inhibitors of HDAC8 Enzyme Activity.

Journal of medicinal chemistry·2026
Same journal

Discovery of a Potent NAMPT-Targeting PROTAC for the Suppression of Triple-Negative Breast Cancer via Macrophage Reprogramming.

Journal of medicinal chemistry·2026
Same journal

3',4'-Isopropylidene-α-galactosylceramide Enables Multidose Th1 Adjuvanticity Despite Limited Serial Serum IFN-γ Responsiveness.

Journal of medicinal chemistry·2026
Same journal

A Bioorthogonally Cleavable <i>N</i>-Oxide Linker for Prodrug Design: Elucidating the Structure-Cyclization Kinetics Relationships for Controlled Drug Release.

Journal of medicinal chemistry·2026
Same journal

A Melatonin-Catechol Hybrid Molecule Prolongs Lifespan via Regulating ROS and Reprogramming Mitochondrial Metabolism.

Journal of medicinal chemistry·2026
Same journal

Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single Administration.

Journal of medicinal chemistry·2026
See all related articles

Researchers synthesized novel cyclic peroxy ketals for antimalarial drug development. Structure-activity relationships guided the creation of potent new peroxides, showing promise against malaria parasites.

Area of Science:

  • Medicinal Chemistry
  • Organic Synthesis
  • Parasitology

Background:

  • Cyclic peroxy ketals are a class of organic compounds with potential biological activity.
  • Antimalarial drug discovery is crucial due to the increasing resistance to existing treatments.
  • Artemisinin derivatives are highly effective but face challenges like resistance and supply issues.

Purpose of the Study:

  • To synthesize and characterize new cyclic peroxy ketals.
  • To evaluate the in vitro antimalarial activity of these novel compounds.
  • To establish structure-activity relationships (SAR) for optimizing antimalarial potency.

Main Methods:

  • A two-step synthetic protocol was employed, starting from readily available aryl methyl ketones.
  • Over 20 new cyclic peroxy ketals were prepared.

Related Experiment Videos

  • In vitro antimalarial assays were conducted to determine IC50 values.

    • Main Results:

    • Seven new peroxides were designed and synthesized based on SAR studies.
    • These compounds exhibited in vitro antimalarial IC50 values ranging from 31-85 nM.
    • The potency of the synthesized compounds was compared to artemisinin (IC50 = 8.4 nM).

    Conclusions:

    • The study successfully generated novel cyclic peroxy ketals with significant in vitro antimalarial activity.
    • SAR generalizations were discussed, providing insights for future optimization of antimalarial drug candidates.
    • The developed compounds represent promising leads for the development of new antimalarial therapies.